Skip to main content
SkinCited

Vitamin D para Vitiligo

D Investigación Solo existe investigación preliminar (estudios de laboratorio, informes de casos).

Research suggests vitamin D deficiency is common in vitiligo patients. Supplementation may support melanocyte function, but clinical evidence for repigmentation is limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dvitiligo'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

Conclusión

Research suggests vitamin D deficiency is common in vitiligo patients. Supplementation may support melanocyte function, but clinical evidence for repigmentation is limited.

Key Study Findings

retrospective observational with Mendelian randomization
Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study.
Dose: None vs: Placebo Efecto: OR 1.86 (95% CI 1.19-2.92) 0.007
Observational Study n=573
Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
Dose: None vs: None Outcome: Vitiligo prevalence and clinical characteristics Efecto: None None

Población: Saudi patients with vitiligo (573)

Meta-Analysis n=680823
Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis.
Dose: None vs: Placebo Efecto: Vitamin D deficiency OR 10.13 (95% CI 4.24-24.20) None
Observational Study
Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study.
Dose: 36% vs: None Outcome: hair regrowth Efecto: None p < 0.05

Población: Aa referred to our hospitals between 2018 and 2021

Other n=38 36 weeks
Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients.
Dose: 92.1% vs: None Outcome: None Efecto: None None

Población: lsa by a paediatric dermatologist

Key Statistics

4

Estudios

300

Participantes

Positive

D

Calificación

Referenced Papers

Journal of the … 2020 57 citas
American journal of … 2018 138 citas
Postepy dermatologii i … 2016 59 citas
The British journal … 2014 74 citas
Journal of cutaneous … 2014 35 citas
Pediatric clinics of … 2014 25 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
600-800 IU/day (RDA)
skinhealth:
1,000-4,000 IU/day (targeting 30-50 ng/mL serum 25(OH)D)

Límite superior: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Mixed --
None -- Neutral 573
None -- Positive 680823
None -- Negative 90
36% -- Mixed --
92.1% 36 weeks Positive 38
None -- Positive 8314220
None -- Negative --

Mejor momento para tomar: With meals containing fat for better absorption

Safety & Side Effects

Efectos secundarios reportados

  • Generally well-tolerated at recommended doses
  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones (rare, at excessive doses)

Interacciones conocidas

  • Thiazide diuretics (may increase calcium levels)
  • Corticosteroids (may reduce vitamin D absorption)
  • Orlistat and cholestyramine (reduce absorption of fat-soluble vitamins)
  • Calcipotriene (additive vitamin D effect)

Ingesta máxima tolerable: 4,000 IU/day (IOM); many experts consider up to 10,000 IU/day safe

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Vitamin D help with Vitiligo?
Based on 4 studies with 300 participants, there is preliminary evidence that needs more research that Vitamin D may support Vitiligo management. Our evidence grade is D (Very Early Research).
How much Vitamin D should I take for Vitiligo?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Generally well-tolerated at recommended doses, Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones (rare, at excessive doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Vitiligo?
We rate the evidence as Grade D (Very Early Research). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Vitamin D para otras condiciones

References

  1. [1] Yuting Cao et al.. Skin Res Technol. 2024. Association of vitamin D with risk of warts: A retrospective and Mendelian randomization study. doi:10.1111/srt.13911 PubMed
  2. [2] Mohammed Ibrahim AlJasser. Clin Cosmet Investig Dermatol. 2024. Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients. doi:10.2147/CCID.S499794 PubMed
  3. [3] Sophia Ly et al.. Am J Clin Dermatol. 2023. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis. doi:10.1007/s40257-023-00805-4 PubMed
  4. [4] Elham Hamidpour et al.. Health Sci Rep. 2023. Effects of age and sex on the comorbidities of alopecia areata: A cross-sectional hospital-based study. doi:10.1002/hsr2.1444 PubMed
  5. [5] N M Dawoud et al.. J Cosmet Dermatol. 2023. Serum brain-derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case-control … doi:10.1111/jocd.15725 PubMed
  6. [6] Basak Yalici-Armagan et al.. Int J Clin Pract. 2021. Paediatric lichen sclerosus et atrophicus: A retrospective analysis of 38 paediatric patients. doi:10.1111/ijcp.14661 PubMed
  7. [7] R Z Conic et al.. J Eur Acad Dermatol Venereol. 2020. Comorbidities in pediatric alopecia areata. doi:10.1111/jdv.16727 PubMed
  8. [8] Elio Kechichian et al.. Am J Clin Dermatol. 2018. Vitamin D and the Skin: An Update for Dermatologists. doi:10.1007/s40257-017-0323-8 PubMed
  9. [9] Ebru Karagün et al.. Postepy Dermatol Alergol. 2016. The role of serum vitamin D levels in vitiligo. doi:10.5114/pdia.2016.59507 PubMed
  10. [10] A Aksu Cerman et al.. Br J Dermatol. 2014. Vitamin D deficiency in alopecia areata. doi:10.1111/bjd.12980 PubMed
  11. [11] Heidi Wat et al.. J Cutan Med Surg. 2014. Off-label uses of topical vitamin D in dermatology: a systematic review. doi:10.2310/7750.2013.13109 PubMed
  12. [12] Nanette B Silverberg. Pediatr Clin North Am. 2014. Pediatric vitiligo. doi:10.1016/j.pcl.2013.11.008 PubMed
  13. [13] Michael P Pender. Autoimmune Dis. 2012. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. doi:10.1155/2012/189096 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.